Track topics on Twitter Track topics that are important to you
Ablexis, LLC, was founded in December 2009 based on technology established by Aliva Biopharmaceuticals, Inc. Ablexis is developing the AlivaMab Mouse, an innovative, next-generation transgenic mouse platform intended to provide the foundation for the efficient discovery and development of the next wave of human therapeutic antibodies. Ablexis has filed patent applications covering its core technologies, compositions and utilities for its AlivaMab mice. The company is based in San Francisco, Calif. More information can be found by visiting the companyâs website at www.ablexis.com.
BURLINGAME, Calif., Sept. 14, 2017 (GLOBE NEWSWIRE) -- Ablexis, LLC, a biopharmaceutical company focused on licensing its AlivaMab Mouse technology for antibody drug discovery, today announced ...
Life Sciences Jobs ...
Ablexis, LLC, was founded in December 2009 based on technology established by Aliva Biopharmaceuticals, Inc. Ablexis is developing the AlivaMab Mouse, an innovative, next-generati...
We have published hundreds of Ablexis, LLC news stories on BioPortfolio along with dozens of Ablexis, LLC Clinical Trials and PubMed Articles about Ablexis, LLC for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Ablexis, LLC Companies in our database. You can also find out about relevant Ablexis, LLC Drugs and Medications on this site too.
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...